期刊文献+

血清和胸腔积液降钙素原对肺炎旁胸腔积液病情评估和诊治的临床价值 被引量:7

The clinical value of S-PCT and PF-PCT in evaluation and treatment of patients with parapneumonic pleural effusion
暂未订购
导出
摘要 目的评价血清降钙素原(S-PCT)和胸腔积液降钙素原(PF-PCT)水平在肺炎旁胸腔积液(PPPE)患者病情评估和诊治中的临床价值。方法80例PPPE患者分为两组:单纯性肺炎旁胸腔积液(UCPE)组42例、复杂性肺炎旁胸腔积液(CPE)组38例,另选定30例漏出液患者作为对照组。检测3组胸腔积液的pH值、葡萄糖、LDH,S-PCT和PF-PCT水平。结果3组胸腔积液的pH值、葡萄糖、LDH均有统计学意义(均P<0.05)。UCPE组、CPE组S-PCT和PF-PCT均较对照组明显升高(均P<0.01),UCPE组、CPE组间S-PCT无统计学意义(P>0.05),UCPE组、CPE组问PF-PCT有统计学意义(P<0.05);S-PCT与PF-PCT之间呈正相关性(r=0.70,P<0.05)。S-PCT与PF-PCT在肺炎严重指数(PSI)评分分层的高风险者明显升高(P<0.05),住院天数>3周和发生并发症及死亡者的S-PCT及PF-PCT分别较住院天数<3周和未发生并发症及死亡者的明显增高,均有统计学意义(均P<0.05),胸膜增厚者和外科手术者PF-PCT/S-PCT分别较非胸膜增厚者和非外科手术者明显下降,均有统计学意义(均P<0.05);PF-PCT>0.25ng/ml(临界值)时被认为对CPE有诊断意义,敏感度为80%,特异度为76%。结论S-PCT和PF-PCT对PPPE病情评估有临床意义;PF-PCT对CPE有诊断意义,可对临床治疗起到指导作用;PF-PCT/S-PCT可以预测胸膜增厚程度和外科手术率。 Objective To investigate the application of serum and pleural fluid procalcitonin(S-PCT and PF-PCT) levels in evaluation of patients with parapneumonic pleural effusion (PPPE). Methods Eighty patients with PPPE were included in the study, including 42 cases of uncomplicated pleural effusion (UCPE) and 38 cases of complicated pleural effusion (CPE) ; 30 pa- tients with transudate patients served as controls. The PH, glucose and lactate dehydrogenase (LHD) levels in pleural fluid or in trasnudate as well as S-PCT and PF-PCT were measured in three groups. Results There were significantly difference in PH, glucose and LDH among three groups (P〈0.05).The levels of S-PCT and PF-PCT were higher in PPPE patients than those in controls(P〈0.01). There were no significantly difference in S-PCT levels between UCPE and CPE groups(P〉0.05),but the differ- ence in PF-PCT levels was significant (P〈0.05). The S-PCT level was positively correlated with PF-PCT level in three groups(r= 0.70, P〈0.05). Both S-PCT and PF-PCT levels significantly increased in high risk patients classified by the PSI score (P〈0.05), whose hospital stay〉3 weeks, or in whom complications or death occurred (P〈0.05). PF-PCT/S-PCT levels were significantly decreased in patients who had pteural thickening or need surgical procedures (P〈0.05). The cut-off value of PF-PCT 〉 0.25ng/mL was used for diagnosis of CPE with a sensitivity of 80% and specificity of 76%. Conclusion The levels of S-PCT and PF-PCT can be used in clinical evaluation of patients with PPPE; PF-PCT may differentiate UCPE from CPE, which need thoracic closing drainage, thoracic injection of fibrinotytic agents or possible thoracoscopic surgery for treatment.
出处 《浙江医学》 CAS 2013年第9期747-750,共4页 Zhejiang Medical Journal
  • 相关文献

参考文献8

  • 1Tasabehji W R, AI-Quobaili F A, AI-Daher N A. Usefulness of pro- calcitonin and some inflammatory parameters in septic patients[J]. Saudi Med J, 2008,29(4):520-525.
  • 2Charles P E, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria[J]. BMC infect Dis,2008, 37(8):38-39.
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3117
  • 4周雁玲,蔡曙耘.多层螺旋CT肋骨段内缘胸膜线影在判断少量胸腔积液和胸膜增厚中的临床价值[J].新疆医科大学学报,2010,33(9):1142-1144. 被引量:3
  • 5M 0 Iler B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in communi- ty-acquired pneumonia[J]. BMC Infect Dis,2007,7:10.
  • 6Cakir E, Deniz O, Ozcan O, et al. Pleural fluid and serum procalci- tonin as diagnostic tools in tuberculous pleurisy [J]. Clin Biochem, 2005,38: 234-238.
  • 7Lin M C, Chen Y C, Wu J T, et aI.Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions [J]. Chest,2009,136(1):205-211.
  • 8Ko Y C, Wu W P, Hsu C S,et al. Serum and pleural fluid procalci- tonin in predicting bacterial infection in patients with parapneu- monic effusion[J]. J Korean Med Sci,2009,24(3):398-402.

二级参考文献25

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:792
  • 3李果真.临床CT诊断学[M].北京:中国科技出版社,1994.302-303.
  • 4Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 5de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 6Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 7Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 8Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 9Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 10Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.

共引文献3118

同被引文献67

  • 1吴茅,林慧君,徐妍.对浆膜腔积液高中性粒细胞图文报告模式的探讨[J].江西医学检验,2007,25(5):413-414. 被引量:3
  • 2Wang CY,Hsiao YC,Jerng JS,et al.Diagnostic value of procalcitonin in pleural effusions[J].Eur J Clin Microbiol Infect Dis,2011,30(3):313-318.
  • 3Rasmussen TA,Sogaard OS,Camara C,et al.Serum procalcitonin in pulmonary tuberculosis[J].Int J Tuberc Lung Dis,2011,15(2):251-256.
  • 4Shomali W,Hachem R,Chaftari AM,et al.Can Procalcitonin Distinguish Infectious Fever From Tumor-Related Fever in Non-Neutropenic Cancer Patients[J].Cancer,2012,118(23):5823-5829.
  • 5Lin MC,Chen YC,Wu JT,et al.Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions [J].Chest,2009,136(1):205-211.
  • 6Wu MH,Lin CC,Huang SL,et al.Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia A systematic review and meta-analysis[J].Influenza Other Respi Viruses,2013,7(3):349-355.
  • 7Horie M,Ugajin M,Suzuki M,et al.Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia[J].Am J Med Sci,2012,343(1):30-35.
  • 8Kang YA,Kwon SY,Yoon HI,et al.Role of C-reactive protein and procalcitonin in differen tiation of tuberculosis from bacterial community acquired pneumonia[J].Korean J Intern Med,2009,24(4):337-342.
  • 9Aggarwal D,Mohapatra PR,Aggarwal P.Serum procalcitonin level:clinical significance[J].Eur Respir J,2011,37(3):723.
  • 10Haeuptle J,Zaborsky R,Fiumefreddo R,et al.Prognostic value of procalcitonin in Legionella pneumonia[J].Eur J Clin Microbiol Infect Dis,2009,28(1):55-60.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部